Yu Yu

457 total citations
6 papers, 197 citations indexed

About

Yu Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Yu Yu has authored 6 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology. Recurrent topics in Yu Yu's work include Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Yu Yu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Yu Yu collaborates with scholars based in China. Yu Yu's co-authors include Jiuwei Cui, Lei Qian, Naifei Chen, Fei Chen, Tao Zhou, Wenqian Li, Yuguang Zhao, Rilan Bai, Ying‐Jie Zhu and Na Wang and has published in prestigious journals such as Frontiers in Oncology, Cell & Bioscience and Oncology Letters.

In The Last Decade

Yu Yu

6 papers receiving 193 citations

Peers

Yu Yu
Comparison fields: 5 of 53
  • Oncology 139
  • Pulmonary and Respiratory Medicine 60
  • Immunology 53
  • Molecular Biology 32
  • Cancer Research 31
Koichiro Nozaki Japan
Silvana Acquafredda Italy
Marie Naigeon France
Nicholas Venturini United States
Weigang Xiu China
Sanjeev Deva New Zealand
Aleigha Lawless United States
Luigi Della Gravara Italy
Patricia Iranzo Spain
Robert A. Belderbos Netherlands
Koichiro Nozaki Japan View profile →
Citations per field, relative to Yu Yu
Yu Yu · 1×
Citations per year, relative to Yu Yu
Yu Yu · 1×

Countries citing papers authored by Yu Yu

Since Specialization
Citations

This map shows the geographic impact of Yu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Yu more than expected).

Fields of papers citing papers by Yu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Yu. The network helps show where Yu Yu may publish in the future.

Co-authorship network of co-authors of Yu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Yu. A scholar is included among the top collaborators of Yu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Yu. Yu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
# Title Journal Authors Indexed citations
1 Measuring the COVID-19 treatment efficiency in OECD countries: a multiplicative network DEA approach INFOR Information Systems and Operational Research Yu Yu, Weiwei Zhu et al. 1
2 Meloxicam inhibits STING phosphorylation and alleviates intracellular DNA-mediated autoimmune responses Cell & Bioscience Yu Yu, Miao Wang et al. 7
3 Cost‐effectiveness of icotinib versus whole‐brain irradiation with or without chemotherapy in EGFR‐mutant NSCLC patients with brain metastases Asia-Pacific Journal of Clinical Oncology Wenqian Li, Rilan Bai et al. 7
4 Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Meta-Analysis Frontiers in Oncology Fei Chen, Naifei Chen et al. 33
5 Present and future of cancer immunotherapy: A tumor microenvironmental perspective (Review) Oncology Letters Yu Yu, Jiuwei Cui 63
6 Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients Molecular and Clinical Oncology Yu Yu, Lei Qian et al. 86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026